Growth Analyser Growth Analyser

Tata India Pharma & Healthcare Fund

Direct · IDCW Sectoral / Thematic
NAV i
+0.94% on the day · 20 Nov 2026
SIP calculator Fund card
This is an IDCW option. Its NAV drops each time it pays out, so a return calculated from its NAV understates what investors received. Returns and risk below are blank by design; see the Growth option of the same plan.

In plain words

as of 20 Nov 2026

This fund does not have enough history yet for a reading. Most numbers need at least a year, risk numbers need three.

Key facts

Fund house
Tata Mutual Fund
Category
Sectoral / Thematic (SEBI)
Plan & option
Direct · IDCW
Benchmark i
NIFTY Pharma TRI (tracked via Nippon India Nifty Pharma ETF - Direct Plan)
First NAV
29 Dec 2015 · — of history · 2,684 NAVs
AMFI code
135807
ISIN
INF277K010B0
Expense ratio i
1.09%
Fund size
Not loaded yet

How ₹100 grew

Loading chart…

Returns

Up to 1 year: total change. Longer: yearly (CAGR) i
1M3M6MYTD1Y3Y5Y7Y10YSince launch
This fund——————————
NIFTY Pharma TRI*+10.85%+7.49%+14.67%+25.66%+25.86%+22.31%+16.87%———
Sectoral / Thematic middle fund i+7.16%+0.76%+8.62%+4.78%+4.45%+14.50%+13.44%+17.71%+15.62%—

Category middle = median Direct Growth fund in Sectoral / Thematic (145 funds with 3 years). * Benchmark approximated by Nippon India Nifty Pharma ETF - Direct Plan with its expense ratio added back. Blank means not enough history, never zero.

Risk and risk-adjusted return

Last 36 months · risk-free rate 6.5%
Volatility i
—
Category middle 17.4%
Downside volatility i
—
Sharpe ratio i
—
Category middle 0.45
Sortino ratio i
—
Calmar ratio i
—
Positive months
—
Best day (3Y)
—
Worst day (3Y)
—

Against its benchmark

NIFTY Pharma TRI · 36 monthly returns
Alpha i
—
Beta i
—
R² i
—
Up capture i
—
Down capture i
—
Tracking error i
—
Information ratio i
—
Treynor ratio i
—

The worst it has been

Deepest fall i
—
Time to recover i
—
Below its high today i
—
Deepest fall, last 3Y
—

Every 1-year period i

Best
—
Middle
—
Worst
—
Ended in a loss i
—
3-year middle
—
3-year worst
—

One 5-year number depends on its start date. These show what happened across every start date in the fund's life.

What it holds

filed for 31 Oct 2026

Asset mix

Indian equity99.74%
Cash & equivalents0.26%

Company size

Large (top 100)26.8%
Mid (101–250)30.4%
Small (251+)40.2%
Not ranked yet2.4%

How concentrated

Stocks
39
Top 5
29.3%
Top 10
50.1%
Top 20
78.7%
Largest holding
7.89%
Effective stocks i
26.2
Sectors
7
Cash & money market
0.3%

Largest sector: Pharmaceuticals & Biotechnology at 63.7%.

Largest holdings

HoldingSectorWeight
SUN PHARMACEUTICAL INDUSTRIES LTDPharmaceuticals & Biotechnology7.89%
ABBOTT INDIA LTDPharmaceuticals & Biotechnology5.66%
DIVI LABORATORIES LTDPharmaceuticals & Biotechnology5.41%
HEALTHCARE GLOBAL ENTERPRISES LTDHealthcare Services5.25%
DR REDDYS LABORATORIES LTDPharmaceuticals & Biotechnology5.14%
TORRENT PHARMACEUTICALS LTDPharmaceuticals & Biotechnology4.73%
APOLLO HOSPITALS ENTERPRISE LTDHealthcare Services4.55%
MAX HEALTHCARE INSTITUTE LTDHealthcare Services4.28%
RAINBOW CHILDRENS MEDICARE LTDHealthcare Services4.02%
SAI LIFE SCIENCES LTDPharmaceuticals & Biotechnology3.22%
SYNGENE INTERNATIONAL LTDHealthcare Services3.17%
PROCTER & GAMBLE HEALTH LTDPharmaceuticals & Biotechnology3.15%
LUPIN LTDPharmaceuticals & Biotechnology3.13%
CIPLA LTDPharmaceuticals & Biotechnology3.08%
ANTHEM BIOSCIENCES LTDPharmaceuticals & Biotechnology2.99%
NATCO PHARMA LTDPharmaceuticals & Biotechnology2.86%
FDC LTDPharmaceuticals & Biotechnology2.69%
BAYER CROPSCIENCE LTDFertilizers & Agrochemicals2.68%
PFIZER LTDPharmaceuticals & Biotechnology2.40%
ACUTAAS CHEMICALS LTDPharmaceuticals & Biotechnology2.40%
ASTER DM QUALITY CARE LTDHealthcare Services2.33%
BIOCON LTDPharmaceuticals & Biotechnology2.23%
NAVIN FLUORINE INTERNATIONAL LTDChemicals & Petrochemicals2.15%
SANOFI CONSUMER HEALTHCARE INDIA LTDPharmaceuticals & Biotechnology1.99%
AJANTA PHARMA LTDPharmaceuticals & Biotechnology1.59%
ALKEM LABORATORIES LTDPharmaceuticals & Biotechnology1.40%
DR. AGARWALS HEALTH CARE LTDHealthcare Services1.31%
GILLETTE INDIA LTDPersonal Products1.25%
NESTLE INDIA LTDFood Products1.09%
SUMITOMO CHEMICAL INDIA LTDFertilizers & Agrochemicals1.01%
PRASOL CHEMICALS LTDChemicals & Petrochemicals0.85%
GLAXOSMITHKLINE PHARMACEUTICALS LTDPharmaceuticals & Biotechnology0.69%
MANIPAL HEALTH ENTERPRISES LTDHealthcare Services0.57%
ZIM LABORATORIES LTDPharmaceuticals & Biotechnology0.57%
MOLBIO DIAGNOSTICS LTDHealthcare Equipment & Supplies0.53%
GUJARAT FLUOROCHEMICALS LTDChemicals & Petrochemicals0.51%
SYMBIOTEC PHARMALAB LTDPharmaceuticals & Biotechnology0.48%
PI INDUSTRIES LTDFertilizers & Agrochemicals0.46%
DR. LAL PATH LABS LTDHealthcare Services0.03%

Sectors

Pharmaceuticals & Biotechnology63.7%
Healthcare Services25.5%
Fertilizers & Agrochemicals4.2%
Chemicals & Petrochemicals3.5%
Personal Products1.2%
Food Products1.1%
Healthcare Equipment & Supplies0.5%

What the manager did last month

30 Sep 2026 → 31 Oct 2026
Bought
₹0 Cr
Sold
₹0 Cr
New positions
1
Sold out of
3

A holding's value moves with its price; only a change in the number of shares is a decision. These lists use share counts. A split or bonus also changes share counts, so check sudden round multiples.

New 1

NESTLE INDIA LTD

Added to 12

TORRENT PHARMACEUTICALS LTD
MAX HEALTHCARE INSTITUTE LTD
SAI LIFE SCIENCES LTD
PROCTER & GAMBLE HEALTH LTD
ANTHEM BIOSCIENCES LTD
NATCO PHARMA LTD
FDC LTD
ASTER DM QUALITY CARE LTD

Trimmed 7

DIVI LABORATORIES LTD
CIPLA LTD
ALKEM LABORATORIES LTD
SYMBIOTEC PHARMALAB LTD
PI INDUSTRIES LTD
DR. LAL PATH LABS LTD
IPCA LABORATORIES LTD

Sold out 3

FORTIS HEALTHCARE LTD₹0.0 Cr
MANKIND PHARMA LTD₹0.0 Cr
JUBILANT PHARMOVA LTD₹0.0 Cr

Against similar funds

Top Sectoral / Thematic Direct Growth funds by return. A sort by one past number, not a recommendation.

FundReturnVolatilitySharpeAlphaBetaDeepest fallStars
HDFC Defence Fund
HDFC
+31.36%30.9%0.80——−34.54%★★★★★
Nippon India Taiwan Equity Fund
Nippon India
+31.07%42.4%0.58+30.90%−0.14−47.10%★★★★★
HDFC Pharma and Healthcare Fund
HDFC
+30.70%15.8%1.53+7.32%0.97−14.91%★★★★★
SBI HEALTHCARE OPPORTUNITIES FUND
SBI
+24.78%14.1%1.30+5.05%0.86−30.53%★★★★★
HDFC Transportation and Logistics Fund
HDFC
+24.43%19.1%0.94+10.99%1.02−23.50%★★★★★
Mirae Asset Healthcare Fund
Mirae Asset
+24.02%15.5%1.13+3.14%0.96−19.98%★★★★★
UTI - Healthcare Fund
UTI
+23.24%15.4%1.09+2.96%0.91−27.10%★★★★★
Aditya Birla Sun Life Transportation and Logistics Fund
ABSL
+23.16%19.9%0.84+9.40%1.09−28.25%Not rated
ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND
ICICI Pru
+22.67%18.9%0.86+9.10%1.06−23.58%★★★★★
LIC MF Healthcare Fund
LIC
+21.83%15.5%0.99+2.12%0.90−15.10%★★★★★
Compare side by side with another Sectoral / Thematic fund
vs Aditya Birla Sun Life Banking and Financial Services Fundvs Aditya Birla Sun Life Business Cycle Fundvs Aditya Birla Sun Life Conglomerate Fundvs Aditya Birla Sun Life Consumption Fundvs Aditya Birla Sun Life Digital India Fundvs Aditya Birla Sun Life ESG Integration Strategy Fundvs Aditya Birla Sun Life Infrastructure Fundvs Aditya Birla Sun Life International Equity Fundvs Aditya Birla Sun Life Manufacturing Equity Fundvs Aditya Birla Sun Life MNC Fundvs Aditya Birla Sun Life Pharma and Healthcare Fundvs Aditya Birla Sun Life PSU Equity Fundvs Aditya Birla Sun Life Quant Fundvs Aditya Birla Sun Life Special Opportunities Fundvs Aditya Birla Sun Life Transportation and Logistics Fundvs Axis ESG Integration Strategy Fundvs Bajaj Finserv Banking and Financial Services Fundvs Bajaj Finserv Consumption Fundvs Bajaj Finserv Healthcare Fundvs Bank of India Banking & Financial Services Fundvs Bank of India Business Cycle Fundvs Bank of India Consumption Fundvs BANK OF INDIA MANUFACTURING & INFRASTRUCTURE FUNDvs Baroda BNP Paribas Banking and Financial Services Fundvs Baroda BNP Paribas Business Conglomerates Fundvs Baroda BNP Paribas Business Cycle Fundvs Baroda BNP Paribas Energy Opportunities Fundvs Baroda BNP Paribas ESG Best-in-Class Strategy Fundvs Baroda BNP Paribas Health and Wellness Fundvs Baroda BNP Paribas India Consumption Fundvs Baroda BNP Paribas Innovation Fundvs Baroda BNP Paribas Manufacturing Fundvs Edelweiss Business Cycle Fundvs Edelweiss Consumption Fundvs Edelweiss Financial Services Fundvs Edelweiss Recently Listed IPO Fundvs Edelweiss Technology Fundvs Franklin Asian Equity Fundvs Franklin Build India Fundvs Franklin India Multi-Factor Fundvs Franklin India Opportunities Fundvs Franklin India Technology Fundvs HDFC Banking & Financial Services Fundvs HDFC Business Cycle Fundvs HDFC Consumption Fundvs HDFC Housing Opportunities Fundvs HDFC Infrastructure Fundvs HDFC INNOVATION FUNDvs HDFC Manufacturing Fundvs HDFC MNC Fundvs HDFC Pharma and Healthcare Fundvs HDFC Transportation and Logistics Fundvs ICICI Prudential Active Momentum Fundvs ICICI Prudential Banking & Financial Services Fundvs ICICI Prudential Bharat Consumption Fundvs ICICI Prudential Business Cycle Fundvs ICICI Prudential Commodities Fundvs ICICI Prudential Conglomerate Fundvs ICICI PRUDENTIAL ENERGY OPPORTUNITIES FUNDvs ICICI Prudential Equity Minimum Variance Fund

If you had run a SIP i

Needs 5 years of NAV history.

Try your own amount and dates

All plans and options

SchemeNAVAMFI code
Direct · Growth₹40.2296135810
Direct · IDCW₹38.9215135807
Direct · IDCW₹38.9215135808
Regular · Growth₹33.9323135812
Regular · IDCW₹32.6347135809
Regular · IDCW₹32.6347135811

About Sectoral / Thematic funds

The rule
At least 80% in one sector (banking, pharma, IT ...) or theme (consumption, manufacturing ...).
Who it can suit
Investors adding a deliberate bet on top of a diversified core.
Typical holding period
7 years or more

Questions people ask

What is the NAV of Tata India Pharma & Healthcare Fund?

₹38.9215 as of 20 Nov 2026, from AMFI's daily NAV file. NAVs are published once every business day after markets close.

Direct or Regular: what is the difference?

Same portfolio. Regular pays a distributor commission inside its fee, so it returns a little less every year.

Growth or IDCW?

Growth reinvests everything. IDCW pays some out, so its NAV drops after each payout and its NAV-based return understates what investors received.

How are these numbers calculated?

Every figure is computed by Growth from the fund's published NAV history. See How we calculate.

Search Growth